Cedric O'Gorman - 23 May 2023 Form 4 Insider Report for RELMADA THERAPEUTICS, INC. (RLMD)

Role: Chief Medical Officer
Signature: /s/ Cedric O'Gorman
Issuer symbol: RLMD
Transactions as of: 23 May 2023
Net transactions value: +$31,800
Form type: 4
Filing time: 24 May 2023, 09:00:22 UTC
Previous filing: 13 Jan 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	RLMD	Common Stock	Purchase	$31,800	+10,000	+8264%	$3.18	10,121	23 May 2023	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The number of securities reported represents an aggregate number of shares purchased in multiple open market transactions over a range of purchase prices. The price reported represents the weighted average price. The Reporting Person undertakes to provide to the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares purchased by the Reporting Person at each separate price within the range.
F2	Purchase prices range from $3.135 to $3.2096 per share, inclusive.

Content

The number of securities reported represents an aggregate number of shares purchased in multiple open market transactions over a range of purchase prices. The price reported represents the weighted average price. The Reporting Person undertakes to provide to the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares purchased by the Reporting Person at each separate price within the range.

Purchase prices range from $3.135 to $3.2096 per share, inclusive.